1

Nyxoah

#7924

Rank

$296.86M

Marketcap

BE Belgium

Country

Nyxoah
Leadership team

Mr. Robert Taub MBA (Co-Founder & Chairman)

Mr. Olivier Taelman (CEO & Exec. Director)

Mr. Loic Moreau (Chief Financial Officer)

Products/ Services
Health Care, Medical, Medical Device, Neuroscience
Number of Employees
100 - 500
Headquarters
Mont-saint-guibert, Brabant Wallon, Belgium
Established
2009
Company Registration
SEC CIK number: 0001857190
Revenue
2M - 5M
Traded as
NYXH
Social Media
Overview
Location
Summary
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
History

Nyxoah was founded in 2014 in Lausanne, Switzerland, and has since rapidly developed its innovative Neurostimulation Therapy platform. The platform is designed to provide personalized, non-invasive, and virtually silent sleep therapy to people living with OSA.

Mission
Our mission is to become the global leader in sleep-disordered breathing solutions by developing innovative, minimally-invasive OSA therapies that restore natural, healthy sleep.
Vision
Our vision is to reduce the burden of OSA on patients and their families, mankind, and the healthcare system worldwide.
Key Team

Ms. Dorit Nahari (VP of Operations)

Mr. Bruno Onkelinx (Chief Technology Officer)

Mr. Jeremy Feffer (VP of Investor Relations & Corp. Communication)

Ms. An Moonen (Gen. Counsel)

Recognition and Awards
Nyxoah has been recognized globally by multiple awards, including the Data Driven Health Award and the Microsoft Accelerator Award.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Nyxoah
Leadership team

Mr. Robert Taub MBA (Co-Founder & Chairman)

Mr. Olivier Taelman (CEO & Exec. Director)

Mr. Loic Moreau (Chief Financial Officer)

Products/ Services
Health Care, Medical, Medical Device, Neuroscience
Number of Employees
100 - 500
Headquarters
Mont-saint-guibert, Brabant Wallon, Belgium
Established
2009
Company Registration
SEC CIK number: 0001857190
Revenue
2M - 5M
Traded as
NYXH
Social Media